BCHE and Alzheimer disease: Gnetol, scirpusin A, scirpusin B, and ε-viniferin all engage with cholinergic pathways, either by inhibiting BChE or modulating acetylcholine receptors, rendering them particularly pertinent for mitigating cognitive decline in AD.